Comprehensive profiling of the human viral exposome in households containing an at‐risk child with mitochondrial disease during the 2020–2021 COVID‐19 pandemic

Abstract

Abstract Background Viral infection is a major cause of morbidity in children with mitochondrial disease (MtD). As a result, families with children with MtD are highly adherent to risk mitigation behaviours (RMBs) advised by the Centers for Disease Control and Prevention during the COVID‐19 pandemic that can modulate infection risk. Methods Deep serologic phenotyping of viral infections was performed via home‐based sampling by combining SARS‐CoV‐2 serologic testing and phage display immunoprecipitation and sequencing. Samples were collected approximately 1 year apart (October 2020 to April 2021 and October 2021 to March 2022) on households containing a child with MtD. Results In contrast to our first collection in 2020–2021, SARS‐CoV‐2 antibody profiles for all participants in 2021–2022 were marked by greater isotype diversity and the appearance of neutralizing antibodies. Besides SARS‐CoV‐2, households (N = 15) were exposed to >38 different respiratory and gastrointestinal viruses during the study, averaging five viral infections per child with MtD. Regarding clinical outcomes, children with MtD (N = 17) experienced 34 episodes of illness resulting in 6 hospitalizations, with some children experiencing multiple episodes. Neurologic events following illness were recorded in five patients. Infections were identified via clinical testing in only seven cases. Viral exposome profiles were consistent with clinical testing and even identified infections not captured by clinical testing. Conclusions Despite reported adherence to RMBs during the COVID‐19 pandemic by families with a child with MtD, viral infection was pervasive. Not all infections resulted in illness in the child with MtD, suggesting that some were subclinical or asymptomatic. However, selected children with MtD did experience neurologic events. Our studies emphasize that viral infections are inexorable, emphasizing the need for further understanding of host‐pathogen interactions through broad serologic surveillance.

Keywords

• COVID‐19
• infection
• mitochondrial disease
• viral exposome
• VirScan